Table 4.
Odds ratios (ORs) of CTCs, CEA, CA19-9, CTC clusters and their combination to predict recurrence of patients with stage III CRC. N/A: not analyzable due to absence of recurrent.
| Stage III CRC (51 Cases) | No. of Cases | |||
|---|---|---|---|---|
| Recurrence | No Recurrence | Recurrence Rate | (Odds Ratio, OR) | |
| CTCs > 3 | 6 | 4 | 28.6% | 2.6 |
| CTCs ≤ 3 | 15 | 26 | 13.3% | |
| CEA > 5 | 8 | 18 | 30.8% | 5.1 |
| CEA ≤ 5 | 2 | 23 | 8% | |
| CA19-9 > 37 | 4 | 4 | 50% | 6.2 |
| CA19-9 ≤ 37 | 6 | 37 | 14% | |
| With CTC clusters | 4 | 7 | 36.4% | 3.2 |
| Without CTC clusters | 6 | 34 | 15% | |
| CTCs > 3; CEA > 5 | 6 | 7 | 46.2% | 7.3 |
| Others | 4 | 34 | 10.5% | |
| CTCs > 3; CA19-9 > 37 | 2 | 0 | 100% | N/A |
| Others | 8 | 41 | 16.3% | |
| CTCs > 3; With CTC clusters | 3 | 2 | 60% | 8.4 |
| Others | 7 | 39 | 15.2% | |
| CEA > 5; CA19-9 > 37 | 3 | 3 | 50% | 5.4 |
| Others | 7 | 38 | 15.6% | |
| CEA > 5; With CTC clusters | 4 | 5 | 44.4% | 4.8 |
| Others | 6 | 36 | 14.3% | |
| CA19-9 > 37; With CTC clusters | 3 | 3 | 50% | 5.4 |
| Others | 7 | 38 | 15.6% | |
| CTCs > 3; CEA > 5; CA19-9 > 37 | 2 | 0 | 100% | N/A |
| Others | 8 | 41 | 16.3% | |
| CTCs > 3; CEA > 5; With CTC clusters | 3 | 1 | 75% | 17.1 |
| Others | 7 | 40 | 14.9% | |
| CTCs > 3; CA19-9 > 37; With CTC clusters | 2 | 0 | 100% | N/A |
| Others | 8 | 41 | 16.3% | |
| CEA > 5; CA19-9 > 37; With CTC clusters | 3 | 3 | 50% | 5.4 |
| Others | 7 | 38 | 15.6% | |
| CTCs > 3; CEA > 5; CA19-9 > 37; With CTC clusters |
2 | 0 | 100% | N/A |
| Others | 8 | 41 | 16.3% | |